Cancel
Known information
- Joined Notch with over 20 years of experience in the biopharmaceutical industry
- Served as Interim Senior Director, Finance at Neoleukin Therapeutics following its merger in 2019 with Aquinox Pharmaceuticals
- Previously, was Senior Director, Finance at Aquinox, where he provided finance leadership in the company's transition to a publicly traded company
- Was Vice President, Finance at Viable Healthworks
- Held senior finance roles at Allon Therapeutics and QLT, Inc.
- Is a Chartered Professional Accountant
- Holds a B.B.A. from Simon Fraser University
About Notch Therapeutics
Notch Therapeutics is a biotechnology company that develops cellular immunotherapies for cancer treatment, utilizing a proprietary platform to engineer pluripotent stem cells into therapeutic cells.
Report inaccurate information
